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A clinical isolate ofBacteroides vulgatus was resistant to tetracycline, clindamycin, ampicillin, cephaloridine,
cefoxitin, and other 13-lactam antibiotics except imipenem. 13-Lactam resistance was mediated by a membrane-
associated, clavulanate-sensitive cephalosporinase capable of degrading cephalosporins and penicillins. Cefox-
itin also was degraded but at a slow rate. The cefoxitin resistance (Fxr) determinant was cloned from B.
vulgatus genomic libraries that were prepared in Escherichia coli and then mated with Bacteroidesfragilis for
the identification of Fxr strains. Analysis of B. fragilis strains with the cloned Fxr determinant revealed the
presence of a new 13-lactamase protein with the physical and enzymatic properties of the 13-lactamase found in
the original B. vulgatus isolate. The 13-lactamase gene (cftA) was subcloned on a 2.2-kb DraI-HindIII fragment,
and the nucleotide sequence was determined. These results showed that cfxA encoded a protein of 321 amino
acids and 35,375 molecular weight. Mutant strains in which the cfxA structural gene was disrupted by
insertional inactivation lost both Fxr and 13-lactamase activity. Comparison of CfxA with other f3-lactamases
showed a relationship with the active-site serine 13-lactamases in the Ambler molecular class A, although CfxA
had apparently diverged significantly. This was exemplified by the substitution in CfxA at 13 of 25 amino acid
residues previously identified as being invariant in class A 13-lactamases. These results suggest that CfxA may
represent a new class A homology group which diverged very early.
,-Lactamase production is the most important mechanism
of resistance to P-lactam antibiotics in gram-negative bacte-
ria, and the Bacteroides fragilis group possesses a wide
array of these enzymes. In general, the organisms are
moderately or highly resistant to many cephalosporins and
penicillins, but a-methoxyl cephamycins such as cefoxitin
and the carbapenems have been highly active against Bacte-
roides species. In the United States, for example, imipenem
resistance rates are presently low, at about 0.2%, and
cefoxitin resistance (Fxr) rates have ranged up to 16% during
the past decade (37, 38). High rates of Fxr are cause for
concern since Fxr strains usually encountered are cross-
resistant to most other P-lactams (38). In the case of strains
that possess metallo-p-lactamases, the cross-resistance in-
cludes the carbapenems (8, 39).
Resistance ofBacteroides species to cefoxitin may involve
a number of mechanisms including altered drug permeabil-
ity, alterations of penicillin binding proteins, 1-lactamase
production, or a combination of mechanisms (8, 10, 41).
Excluding the relatively rare imipenem-hydrolyzing metal-
loenzymes, several P-lactamases capable of cefoxitin degra-
dation have been described. These are generally cephalo-
sporinases with a slow rate of cefoxitin hydrolysis, and they
are sensitive to inhibition by clavulanate (9, 13). Recently,
Aldridge et al. (1) have found that >93% of Fxr strains were
still sensitive to 3-lactam-clavulanate combinations. Thus,
based on these criteria, it is possible that the slow cefoxitin-
hydrolyzing cephalosporinases are one of the most widely
disseminated mechanisms of Fxr in the Bacteroides species.
In this regard, it has been suggested that these P-lactamases
are not novel enzymes but rather that the strains are Fxr
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because of the production of much greater than normal
levels of the conventional Bacteroides enzyme (36).
The occurrence of high regional Fxr rates indicates the
potential for clonal dissemination and/or horizontal transfer
of the resistance phenotype. The transfer of Fxr by a
conjugation-like mechanism has been demonstrated; how-
ever, plasmids were not involved in the transfer (10). The
Fxr phenotype was mediated by the acquisition of a new
P-lactamase. The present study was initiated to define the
genetic basis for transmissible Fxr in Bacteroides species.
The results revealed a novel genetic locus designated cfx4,
which encodes an Ambler molecular class A 13-lactamase
that appears to have diverged significantly from all other
class A enzymes.
MATERIALS AND METHODS
Bacterial strains and growth. Bacteroides cells were cul-
tured anaerobically in supplemented brain heart infusion
broth as described previously (31). The following antibiotic
concentrations were used unless noted in the text: clindamy-
cin, 5 ,ug/ml; tetracycline, 5 ,ug/ml; rifampin, 20 ,ug/ml;
gentamicin, 25 p,g/ml; cefoxitin, 20 p,g/ml; ampicillin, 50
,g/ml; and spectinomycin, 40 ,ug/ml. Antibiotic MIC values
were measured by the standard agar dilution method with
Wilkins-Chalgren medium (Difco Laboratories, Detroit,
Mich.). Values were determined after 48 h of growth.
B. vulgatus CLA341, a cefoxitin-, tetracycline-, and clin-
damycin-resistant (Fxr Tcr Ccr) clinical isolate, was obtained
from P. C. Appelbaum at the Hershey Medical Center. B.
fragilis 638 and B. uniformis V528 are Fxs, rifampin-resistant
(Rf') laboratory strains used in routine analysis. Strains
IB246 and IB247 are Fxr Tcr Rf' transconjugants obtained by
mating the B. vulgatus CLA341 donor with 638 and V528,
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respectively. The strains 638(pJST61.cfx), 638(pFD351), and
638(pFD288) are plasmid-containing derivatives of 638 with
the original cloned cfxA gene fragment, a subclone, or the
subcloning vector, respectively. All other Bacteroides
strains are referenced in the appropriate text. Escherichia
coli DHSa (recA hsdR17 lac) was used as the host for all
subcloning experiments, and E. coli HB101 (recA rpsL) was
the primary host used for library construction. These strains
were grown aerobically in L broth (agar) supplemented with
ampicillin or spectinomycin where appropriate.
Bacterial conjugation. Standard filter mating protocols
were used to transfer plasmids in triparental matings from E.
coli donors to Bacteroides recipients. These used E. coli
donor strains containing RK231 as a helper plasmid, and the
mating plates were incubated aerobically as described pre-
viously (29). After 18 h of growth, the filters were washed
with supplemented brain heart infusion broth, the cell sus-
pensions were plated on selective media, and the plates were
incubated anaerobically for selection of Bacteroides trans-
conjugants.
DNA isolation and analysis. Purified plasmid DNA prepa-
rations from Bacteroides cells were obtained by CsCl-ethid-
ium bromide ultracentrifugation of lysates prepared by alka-
line denaturation (31). Genomic DNAs from Bacteroides
strains were prepared from 50-ml overnight cultures and
purified by CsCl-ethidium bromide ultracentrifugation as
described previously (34). Screening and large-scale plasmid
DNA preparations from E. coli transformants were per-
formed as described previously (3). Plasmids were analyzed
by agarose gel electrophoresis with Tris-borate or Tris-
acetate buffers containing ethidium bromide, and other rou-
tine DNA manipulations have been described previously
(31).
DNA hybridization analyses were performed essentially
as described previously (34). Genomic or plasmid DNA
samples were digested with the appropriate restriction en-
donuclease and electrophoresed on 0.8% agarose gels in
Tris-acetate buffer. DNA was transferred from the gels to
nitrocellulose filters by capillary action. DNA probes were
labeled with 32P by the random primer reaction with a
commercial kit (Pharmacia LKB Inc., Piscataway, N.J.).
Hybridizations were performed overnight at 67°C in 3 x SSC
(lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-4x
Denhardt's solution (1x Denhardt's solution is 0.02% bovine
serum albumin, 0.02% polyvinylpyrrolidone, and 0.02%
Ficoll 400 in H20)-1 mg of sheared salmon sperm DNA per
ml. Filters were then washed three times for 30 min at 52°C
in 0.1x SSC-0.1% sodium dodecyl sulfate (SDS) followed
by three 30-min washes in 0.1x SSC at 52°C.
Nucleotide sequence analysis of the pFD351 cfx gene
fragment was performed by Sanger dideoxy sequencing
reactions with modified T7 polymerase (Sequenase; U.S.
Biochemical, Cleveland, Ohio), and reaction mixtures were
analyzed on 6% polyacrylamide gels containing urea. The
DNA fragment was sequenced in the first direction (DraI to
HindIII) by analyzing a set of nested deletions (16) derived
directly from pFD351. Sequence of the second strand was
determined by primer walking of density gradient-purified
pFD351 utilizing oligonucleotide primers deduced from the
sequence of the first DNA strand. The University of Wis-
consin GCG DNA sequence analysis software (12) was used
for computer analysis of DNA and protein sequences. The
Pileup program from this package was used to generate the
progressive multiple alignment of the 13-lactamase protein
sequences. The cM nucleotide sequence has been submit-
ted to GenBank and assigned the accession number M72418.
Other sequences used for analysis together with their abbre-
viations and GenBank accession numbers are as follows:
Staphylococcus aureus (PC1), M15526 (5); Yersinia entero-
colitica (YER), X57074 (28); Bacillus cereus ,B-lactamase III
(BCIII), M15195 (20); B. cereus P-lactamase I (BCI), X06599(30); Actinomadura strain R39 (ACT), X53650 (18); Strepto-
myces albus G (ALBUS), M28303 (11); and E. coli TEM-1
from pBR322, VB0001 (35).
Library and plasmid constructions. A genomic library of
CLA341 was prepared by partial digestion of genomic DNA
with Sau3A. DNA fragments in the 5- to 15-kb size range
were purified on neutral sucrose gradients, pooled, and
ligated to the BglII site of pJST61 (ampicillin resistance [Apr]
in E. coli and Ccr in Bacteroides species [39]). Ligation
mixtures were transformed into E. coli HB101, and transfor-
mants were selected on ampicillin-containing medium.
These recombinants were then mated with B. fragilis 638 for
the identification of Fxr clones as described in the text
below. The Fxr gene was subcloned with the pUC19-based
shuttle vector pFD288 (8.8 kb; oniT Spr in E. coli and Ccr in
Bacteroides species [32]). The suicide vector pFD280.erm
was similar to pFD288 except that is lacked the pBI143
replicon portion of the molecule, rendering it incapable of
replication in Bacteroides species. The construct used for
insertional inactivation of Fxr, pSUC2, was formed by
ligation of the 0.6-kb HaeIII-PvuII fragment (see Fig. 1) into
the SmaI site of pFD280.erm.
Analysis of 1-lactamase activity. Cell extracts were pre-
pared from 200-ml cultures of mid- to late-logarithmic-phase
cells. Cells were harvested by centrifugation, washed in 20
mM phosphate buffer (pH 7), and then suspended in 3 ml of
the same buffer. Cells were disrupted by two passages
through a French pressure cell at 12,000 lb/in2, and cellular
debris were removed by centrifugation at 12,000 x g for 30
min at 4°C. 3-Lactamase activity was routinely measured
with the chromogenic cephalosporin nitrocefin (10-4 M) in a
1-ml reaction mixture with a DU-65 recording spectropho-
tometer (Beckman Instruments, Inc., Fullerton, Calif. [25]).
Substrate profiles were determined by monitoring the hy-
drolysis of various ,B-lactam antibiotics by crude extracts in
1-ml reaction mixtures containing 0.1 mM substrate. Reac-
tions were measured at the following wavelengths: cephalo-
ridine, 260 nm; cefotaxime, 267 nm; cephalothin, 260 nm;
ampicillin, 235 nm; benzylpenicillin, 233 nm (8). The appar-
ent Km values were estimated from double-reciprocal plots
of velocity versus substrate concentration. For all enzymatic
analysis, one unit of activity was defined as the amount of
cell extract that could degrade 1 ,umol of substrate per min.
To test the effects of various inhibitors on 1-lactamase
activity, crude cell extract was incubated with inhibitor for 5
min and the reaction was then initiated by the addition of
nitrocefin. Protein concentrations for all assays were esti-
mated as described previously (24).
Molecular weight determinations. The apparent molecular
weight of 3-lactamase was determined by SDS-polyacryl-
amide gel electrophoresis (PAGE) with a discontinuous
buffer system (23). 3-Lactamase activity in the gels was
detected after renaturing the proteins by soaking the gels in
several changes of sodium phosphate buffer as described by
Foweraker et al. (14). Activity was detected by overlaying
the gels with nitrocefin-containing agarose and photographed
with a green filter. The relative migration of the P-lactamase
bands was compared with the mobilities of protein standards
visualized after staining with Coomassie blue (Coomassie
Brilliant Blue G; Sigma Chemical Co., St. Louis, Mo.).
Location of enzymatic activity. Bacterial cells were frac-
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tionated by a modification of the osmotic shock method
described by Huang and Forsberg (19). Cultures (300 ml)
were centrifuged at 10,000 x g for 15 min at 4°C, and a
sample of the supernatant was saved for analysis of extra-
cellular proteins. Cells were then washed twice in 50 mM
sodium phosphate buffer (pH 7) containing 0.8% NaCl,
suspended in 0.5 M sucrose with 30 mM Tris (pH 7.2) (50 ml
of buffer per g of cells), and then gently shaken for 10 min at
room temperature. Cells were then centrifuged at 20,000 x g
for 20 min at 22°C, quickly suspended in ice-cold H20 (30 ml
of H20 per g of cells), and shaken gently for 10 min at 4°C.
This cell suspension was then centrifuged for 20 min at 4°C,
and the resulting supernatant contained the periplasmic
fraction. The cell pellet was suspended in 5 ml of 20 mM
sodium phosphate buffer (pH 7), apd the cells were ruptured
in a French pressure cell. Cellular debris were removed by
low-speed centrifugation, and the supernatant was then
centrifuged at 200,000 x g for 2 h at 4°C to separate the
cytoplasmic and membrane fractions. The membranes then
were suspended in 5 ml of 20 mM sodium phosphate buffer
(pH 7).
Acid phosphatase and succinate dehydrogenase were used
as marker enzymes for the periplasmic and membrane frac-
tions, respectively. Acid phosphatase was assayed as de-
scribed by the supplier (Sigma procedure no. 104). Succinate
dehydrogenase was measured by observing the oxidation of
NADH in the presence of fumarate. One-milliliter reaction
mixtures containing cell extract in 50 mM sodium phosphate
buffer (pH 7), 0.2 p,mol of NADH, and 2.5 p,mol of disodium
fumarate were incubated at 30°C, and the change inA340 was
recorded. One unit of activity is expressed as micromoles
NADH oxidized per minute.
HPLC assay of cefoxitin in culture supernatants. Cefoxitin
was detected in culture supernatants essentially as described
previously (9). Briefly, cultures were grown overnight and
diluted into fresh broth containing 100 ,ug of cefoxitin per ml
to about 108 cells per ml. These cultures were incubated for
24 h and centrifuged, and the supernatant was retained for
high-pressure liquid chromatographic (HPLC) (Beckman
Instruments) analysis. Samples of supernatant were ana-
lyzed directly on a Supelcosil LC-18-DB (Supelco Inc.,
Bellefonte, Pa.) reverse-phase column (25 cm by 4.6 mm)
with a 25% methanol-75% 10 mM KH2PO4 mobile phase.
Elution was at 1 ml/min and monitored at A234 and A260 for
identification of the drug and possible metabolites. Cefoxitin
was identified and quantified by comparison to known ce-
foxitin standards prepared in supplemented brain heart infu-
sion broth. Under these conditions, cefoxitin eluted at 9.6 ml
and the putative cefoxitin breakdown product (A234 chro-
mophore) eluted at 12 ml.
RESULTS
Cloning and genetic analysis of cfxA. B. vulgatus CLA341
was resistant to tetracycline, clindamycin, and to high levels
of ampicillin, piperacillin, cefoxitin, and other P-lactam
antibiotics except for the carbapenems such as imipenem
(Table 1) (26). Resistance to 3-lactam antibiotics was trans-
missible to other Bacteroides species via a conjugation-like
mechanism (26). To clone this conjugative resistance gene,
we prepared CLA341 genomic libraries using the positive
selection vector pJST61 (39). A total of 6 x 103 E. coli clones
were placed into 20 pools, and these were mated with the
recipient B. fragilis 638 in triparental matings. Following
selection for transconjugants on a medium containing ri-
fampin, gentamicin, clindamycin, and cefoxitin, a single Fxr
TABLE 1. ,-Lactamase activity and in vivo cefoxitin
degradation by Bacteroides strains containing cfx4
Strain/(Plasmid) MIC (p.g/ml) % Cefoxitin ,-Lactamase
Cefoxitin Ampicillin degradationa sp act"
CLA341 256 >256 82 2.1
638(pJST61.cfx) 128 256 91 2.0
638(pFD351) 128 >256 91 5.3 + 2.0
638(pFD288) 8 16 5 0.007
IB246 128 256 89 4.3
IB246flpSUC2C 8 16 2 0.007
638 8 16 11 0.009
IB247 128 256 NDd 1.8
V528 2 2 ND 0.02
a Cefoxitin degradation was determined by HPLC as described in the text,
and results are the average of two trials. There was an average of 1% cefoxitin
defradation in uninoculated controls.
,P-Lactamase activity was determined by nitrocefin assays of crude
extracts. Results are in units per milligram.
c The cfiA gene of strain IB246fQpSUC2 has been inactivated by insertion
of the pSUC2 plasmid (see text).
dND, not determined.
colony was obtained, and this recombinant plasmid contain-
ing the cfxA gene was designated pJST61.cfx. Relative to the
638 parent strain, this transconjugant had a 200-fold increase
in 3-lactamase activity and an increase in both the cefoxitin
and ampicillin MIC (Table 1).
Restriction analysis of pJST61.cfx revealed the presence
of a single 7.5-kb Sau3A fragment (Fig. 1). This fragment
was excised with Sau3A and subcloned into the BamHI site
of the Ap' shuttle vector pFD288. There was no 1-lactamase
activity detected in the resulting E. coli clones. The P-lacta-
mase activity was localized by further subcloning into
pFD288 and testing recombinants for Fxr in B. fragilis 638.
The smallest active subclone was pFD351 with a 2.2-kb
insert (Fig. 1). B. fragilis 638(pFD351) displayed high Fxr
and Apr levels, and ,B-lactamase activity increased 3.6-fold
above the activity seen with pJST61.cfx. This high level of
activity was somewhat variable in the subclones and ranged
from 3 to 7 U/mg of protein (Table 1). No 1-lactamase
activity was observed in the smaller subclones (pFD352,
-353, and -354) which were deleted in the central region of
the DNA fragment containing the HaeIII, ClaI, and PvuII
sites.
Identification and inactivation of the FxF determinant.
CLA341 contains several plasmids, two of which are usually
found in the Fxr progeny that result from matings with
CLA341 as the donor. Genomic DNA from CLA341, IB246
(Fxr transconjugant), and 638, and a CLA341 CsCl-purified
plasmid preparation, were examined for the presence ofcfA
in Southern hybridizations. The results shown in Fig. 2 were
obtained with a 0.6-kb HaeIII-PvuII probe which lies within
the cfi;4 gene (Fig. 1). There were no cfx4-homologous
fragments observed in the CLA341 plasmid preparation or in
the B. fragilis 638 control; however, a single 7.5-kb Sau3A
fragment from genomic CLA341 and IB246 DNA hybridized
strongly to the probe.
To demonstrate the dependence of Fxr on the P-lacta-
mase, we constructed a cfxA mutant by insertional inactiva-
tion. A suicide vector (pFD280.erm) unable to replicate in
Bacteroides species was ligated to the 0.6-kb HaeIII-PvuII
cfi:A gene fragment. This construpt, pSUC2, was mobilized
into the Fxr transconjugant IB246 with selection for the
pSUC2 ermF (Ccr) determinant. Presumably, homologous
recombination with the cfx4 gene should mediate the inser-
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FIG. 1. Restriction endonuclease maps of clones containing cfx4
gene fragments. In all cases, only the CLA341 DNA fragments are
presented and no vector sequences are shown. pJST61.cfx was the
original 7.5-kb insert cloned into pJST61, and all other plasmids
were constructed in the vector pFD288 as described in the text. Fxr
denotes the phenotype of each plasmid in B. fragilis 638. The bar
under the map of pJST61.cfK indicates the region used as probe in
Fig. 2 and 6 and for the construction of IB246Q1pSUC2.
tion of pSUC2 into the chromosome by a single crossover
event leading to the inactivation of c5xA (15). Thirty-two CCr
transconjugants were obtained in two independent matings,
and all those tested had pSUC2 inserted into the chromo-
some. Several of the transconjugants Were tested for ,B-lac-
tamase activity and were found to have low levels of activity
similar to those of the original 638 parental strain (e.g.,
IB246,QpSUC2, Table 1). These strains also were now sen-
sitive to low concentrations of cefoxitin.
Characterization of CfxA 13-lactamase. Preliminary exper-
iments with a bioassay system indicated that crude extracts
of CLA341 or IB246 but not 638 were capable of inactivating
cefoxitin. These results were confirmed and extended by
HPLC analysis. Results shown in Table 1 indicate that
incubation of cefoxitin (100 ptg/ml) with CLA341, IB246,
638(pJST61.cfx), or 638(pFD351) for 24 h resulted in the
disappearance of >80% of the drug. In all cases, the disap-
pearance of the drug coincided with the appearance of a new
metabolite which had a longer retention time and absorbed
strongly at 234 nm. When cefoxitin was incubated with 638,
638(pFD288), or IB246QlpSUC2 cells, there was only a slight
FIG. 2. Agarose gel analysis and autoradiograph of DNAs
probed with the 0.6-kb cfA4 gene fragment. Each lane contains
either 1 ,ug of undigested plasmid DNA or 1 ,ug of total genomic
DNA digested with Sau3A. Lanes: A, CLA341 purified plasmids; B,
CLA341 genomic DNA; C, 638 genomic DNA; D, IB246 genomic
DNA.
decrease in the concentration of drug and no new metabo-
lites were observed.
Typical substrate and inhibitor profiles for CfxA in crude
extracts of CLA341 are presented in Table 2. These results
indicated that the enzyme was a cephalosporinase that had
high hydrolysis activity for cephaloridine,and cephalothin.
Activity with penicillin substrates was less than 11% of the
activity with cephalosporins. The apparent Km values of the
enzyme for cephaloridine and penicillin were 113 and 31 ,uM,
respectively. Although the bioassay and HPLC analysis
clearly indicated degradation of cefoxitin, the rate was too
slow to observe in spectrophotometric assays and no enzy-
matic hydrolysis was detected. The inhibitors clavulanic
acid and sulbactam inhibited the enzyme, causing about 50%
inhibition at 1 ,uM. The enzyme was not significantly inhib-
ited by EDTA, but p-chloromercuribenzoate (PCMB) and
iodine were potent inhibitors.
The molecular mass of CfxA was estimated by SDS-
TABLE 2. Substrate and inhibitor profiles for CfxA
Compound Concn % Activit(p.Mr
Substrates
Cephaloridine 100 100
Cephalothin 100 67.5
Penicillin G 100 10.7
Ampicillin 100 7.2
Cefotaxime 100 0.96
Cefoxitin 100 <0.01
Nitrocefin 100 290
Inhibitors
Clavulanate 1 51
Sulbactam 1 35
PCMB 100 0
EDTA 100 84
Iodine 100 0
a Concentration is the concentration of substrate used for substrate assays
or the concentration of inhibitor used in inhibitor assays with nitrocefin as
substrate.
b The percent activity for substrate assays is the percent activity relative to
that of cephaloridine (100%). In inhibitor assays, the percent activity is
relative to nitrocefin assays with no inhibitor added.
Fx r
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FIG. 3. SDS-PAGE analysis of crude extracts from B. vulgatus
CLA341, Fxr transconjugants, and the 638(pFD351) subclone con-
taining cfx4. Crude extracts containing between 80 and 130 pg of
protein were electrophoresed on 10% polyacrylamide gels and then
stained for P-lactamase activity. The molecular masses (in kilodal-
tons) of protein standards are indicated to the left of the panel.
Lanes: 1, 638(pFD351); 2, IB246; 3, IB247; 4, CLA341; 5, 638; 6,
V528.
PAGE of crude extracts, and the results are shown in Fig. 3.
As seen in lane 4, extracts from CLA341 had a single, but
broad, nitrocefin-reactive band that measured between
35,000 and 38,000 Da. The CfxA 1-lactamase was clearly
distinct from the common 3-lactamases seen in B. fragilis
638 or B. unifonnis V528 (lanes 5 and 6), which were about
30,000 Da. The transconjugants IB246 and IB247 and the
clone 638(pFD351) each possessed the common P-lacta-
mase, but in addition they had acquired a new P-lactamase.
This new protein comigrated with CfxA from CLA341.
Isoelectric focusing is another important analytical tool used
for the analysis of ,B-lactamases, but several attempts by a
variety of methods failed to result in clear, discrete nitroce-
fin-reactive bands for CfxA, although other Bacteroides
,-lactamases were easily visualized.
The cellular location of CfxA activity in B. vulgatus
CLA341 was determined by fractionation of cellular compo-
nents with succinate dehydrogenase and acid phosphatase as
markers for the membrane and periplasmic fractions, respec-
tively. The results in Table 3 show that CfxA activity closely
followed the membrane fraction, with 58% of the total
activity being membrane associated and only 17% of the
activity located in the periplasm. A fraction of the total
succinate dehydrogenase activity also appeared in the cyto-
plasmic and periplasmic fractions, indicating that there may
have been some partitioning of membrane into these frac-
tions. However, only 2% of the acid phosphatase activity
was found in the membrane fraction, indicating that there
was little or no contamination of the membranes with
periplasmic contents. Similar results were observed for the
B. fragilis transconjugant IB246, for which 66 to 78% of the
13-lactamase activity was membrane associated, and in these
experiments, 93% of succinate dehydrogenase was in the
TABLE 3. Cellular location of CLA341 [3-lactamase activity
% Total enzyme activity'
Fraction
,B-Lactamase Acid phosphatase SDHb
Extracellular 6.0 0 0
Periplasmic 17.0 83.6 18.6
Cytoplasmic 19.0 13.6 15.7
Membrane 58.0 2.8 65.6
a The results are the percentage of total activity in crude cell extract, and
values are the average of three replicates from two experiments.
b SDH, succinate dehydrogenase.
membrane fraction. In contrast to these results, 61 to 87% of
the total activity of common 1-lactamase was found in the
periplasmic fraction of B. fragilis ATCC 25285 (33).
Nucleotide sequence analysis of cfxA. The complete nucle-
otide sequence of the 2,141-bp pFD351 cfx4 gene fragment
was determined, and the results are summarized in Fig. 4A.
The sequence information revealed three open reading
frames greater than 500 bp. Overall, the region had a 39%
G+C content similar to the Bacteroides genome, and cfA4
was slightly lower, being 35% G+C. The assignment of cfxA
to the largest open reading frame was consistent with the
subcloning results described above.
The DNA sequence of cfx revealed a potential coding
region of 963 bp starting at the first ATG codon (bp 150) and
ending at the nonsense codon TAA (bp 1112; Fig. 4B). This
could encode a protein of 321 amino acid residues with a
predicted molecular weight of 35,375. A minimal ribosome
binding site (AAA) was adjacent to the ATG start site, but it
is possible that translation may start further upstream within
the leader sequence preceding the ATG. There is a ribosome
binding site (AAAGA) located in this region with four of five
bases complementary to sequences near the B. fragilis 16S
rRNA terminus (3' end, OH-UCUUUCC [40]). Downstream
from the cfixA translation stop codon, at bp 1156, there was
a region of dyad symmetry with the major features of a
transcription terminator.
Relationship between CfxA and Ambler class A 1-lacta-
mases. There was no significant homology between the cfxA
nucleotide sequence and DNA sequences in the GenBank
data base. However, when the CfxA amino acid sequence
was used in data base searches, homology to several Ambler
class A (2) P-lactamases from a variety of species was
observed. The homologies ranged from 22% identity (38%
similarity) for the S. albus enzyme to 27% identity (49%
similarity) for blaZ from S. aureus p1258. Several key
features plus the global sequence alignment (described be-
low) clearly placed CfxA in the class A group. First was the
presence and location of the active-site residues TyrProMet-
MetSerValPheLys (Fig. 4B), which are similar to TEM-1
and also correspond closely to the class A consensus Phe-
(X)3-Ser-(X)2-Lys for active-site serine P-lactamases. Sec-
ond, the invariant SDN loop (21) which may contribute to
the integrity of the catalytic site was present in CfxA.
Based on these preliminary observations, the amino acid
sequences of seven class A enzymes representing different
homology groups (7, 27) were aligned with CfxA by a
progressive alignment program, and the results are shown in
Fig. 5. This alignment agrees closely with the results of
Couture et al. (7) in which 26 class A ,-lactamases were
aligned, and most of their previously found regions of
homology could be identified in our alignment. The pairwise
identity scores for each of these aligned sequences also were
determined, and it was found that CfxA was not closely
related to any specific member of the class A group (Table
4). This analysis suggested that CfxA was most closely
related to the S. aureus, Y. enterocolitica, and S. albus
enzymes, and the least homology was seen with the B.
cereus type III and Actinomadura group.
Homology ofcaxA to other Fx Bacterodes species. An initial
assessment of cfxA dissemination was determined by South-
ern analysis of a panel of Fxr strains. For these analyses, the
internal HaeIII-PvuII gene fragment was used to probe
EcoRI-restricted genomic DNA from four different Bacte-
roides species. The results in Fig. 6 show that seven of the
strains tested contained cfxA homologous sequences and
that the only negative isolate was another B. vulgatus strain.
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FIG. 4. Open reading frames (orf) located on the B. vulgatus pFD351 DNA insert and nucleotide and protein sequence of the region
surrounding the cfxA gene. (A) Major open reading frames of the pFD351 2.2-kb cloned fragment are shown by the hatched marked boxes.
(B) Nucleotide sequence from the region shown in panel A is presented, and below this is the deduced CfxA protein sequence. The first ATG
codon is indicated by the asterisk over the sequence, and two possible ribosome binding sites are underlined and labeled sd. The ClaI, HaelII,
and PvuII sites are labeled, and the putative transcription terminator is shown by the lines over the sequence. The CfxA active-site residues
and the SDN loop are underlined and shown in boldface.
Most of the strains tested were relatively recent isolates
obtained from the Hershey Medical Center or Wadsworth
Anaerobe Laboratory; however, B. fragilis V503 (VPI12256)
was isolated prior to 1978 and this also hybridized strongly to
the probe. It is interesting that four of the strains displayed
more than one homologous fragment, but it was not deter-
mined whether this was due to multiple copies of the gene.
Control hybridization experiments with Fxs strains were
invariably negative when probed with the HaeIII-PvuII cfxA
gene fragment (Fig. 2) (33).
DISCUSSION
The results presented in this report demonstrate that the
transmissible CLA341 Fxr phenotype was mediated by a
novel P-lactamase, CfxA. The results in Fig. 2 document
that the cfxA gene was transferred to recipients strains
during conjugation but that it was not located on plasmid
DNA. Thus, cfx4 may be similar to the transmissible Fxr
determinants described previously which were thought to be
chromosomally located (9, 10). Except for the cellular loca-
tion, CfxA was typical of conventional Bacteroides ceph-
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FIG. 5. Multiple sequence alignment of CfxA with class A ,B-lactamases representing the major homology groups. Sequences are
numbered so that the active-site Ser equals position 70 according to the scheme of Ambler et al. (2) and using the PCi sequence as a reference.
PC1 secondary structures involving four or more residues are underlined and labeled al to all for a helix and ,11 to ,B4 for ,B strand. Highly
conserved regions are bracketed, and the invariant residues (7) are denoted by the asterisk over the sequence. Substitutions in the invariant
residues are underlined and boldfaced. Abbreviations are as follow: S. aureus, PC1; Y enterocolitica, YER; B. cereus f3-lactamase III, BCIII;
B. cereus 1-lactamase I, BCI; Actinomadura strain R39, ACT; S. albus G, ALBUS; and E. coli from pBR322 (Tn3), TEM-1.
alosporinases (Table 2), and these enzymes have been cate-
gorized as members of group 2e in the Bush (4) classification
scheme (clavulanic acid-inhibited cephalosporinases).
Although CfxA was similar to conventional 1-lactamase,
several lines of evidence suggest this is a novel enzyme that
is widely disseminated among Fxr (imipenem sensitive)
Bacteroides species. First, CfxA was distinguished by the
TABLE 4. Percent pairwise identities between aligned class A
P-lactamase protein sequences
% Identityb
Enzyme'
TEM-1 BCIII BCI ACT PC1 ALBUS YER CFXA
TEM-1 100 32 34 30 30 36 35 17
BCIII 100 54 46 40 35 36 16
BCI 100 50 37 34 37 16
ACT 100 34 36 37 15
PC1 100 30 30 21
ALBUS 100 43 20
YER 100 20
CFXA 100
a Abbreviations for enzymes are the same as defined in the legend to Fig. 5.
b The percent identity was determined from the aligned sequences shown in
Fig. 5.
ability to slowly degrade cefoxitin (Table 1), which is not a
property reported for the most common, conventional
Bacteroides enzymes. In this regard, Yotsuji et al. (42) have
shown that ,B-lactamases from strains resistant to high levels
of cephaloridine and benzylpenicillin did not degrade cefox-
itin even though many of these strains had high specific
activity (0.15 to 2.43 U/mg) of the enzymes. Second, DNA
sequences homologous to cfxA were found only in other Fxr
strains, and these represented four different species. If CfxA
was the common chromosomal ,3-lactamase, one would
predict that it would be species specific, with each species
overproducing its own 3-lactamase. Finally, we have shown
previously (34) that the Fxr B. vulgatus strains, WAL7062
and CLA341, are bona fide B. vulgatus species, and the
results presented here indicate that no cfxA-homologous
sequences were present in WAL7062. If Fxr in CLA341 was
due to overproduction of the conventional enzyme, then
WAL7062 should have cfxA-homologous sequences.
Based on enzymatic properties, it was predicted that the
group 2e enzymes would fall in the Ambler molecular class A
(4). The protein sequence deduced from cfxA revealed
homology to several class A enzymes. No class D and class
C enzymes were identified in the data base searches, and
when representatives of these classes were compared indi-
vidually to CfxA, identity or similarity was extremely weak.
CFX
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Pc1
CFX
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ALBUS
YER
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1034 PARKER AND SMITH
BACTEROIDES P-LACTAMASE 1035
FIG. 6. Homology of the cxA4 gene to other Fxr Bacteroides
strains. Genomic DNAs (1 ,±g) digested with EcoRI were electro-
phoresed on a 0.6% agarose gel and then transferred to nitrocellu-
lose filters. The filters were probed with the 0.6-kb HaeIII-PvuII
fragment from cfxiA. Lanes: A, B. vulgatus CLA341; B, B. fragilis
CLA262; C, B. fragilis CLA276; D, B. unifonnis WAL7088; E, B.
fragilis WAL7505; F, B. ovatus WAL7606; G, B. fragilis V503
(VPI12256); H, B. vulgatus WAL7062.
However, homology to class A also was relatively low, and
the highest degree of protein sequence identity in individual
comparisons was 27% to the S. aureus enzyme. The overall
weak identity suggests that cfA4 diverged early from the
group, and in fact, CfxA did not fall within any of the
established class A homology groups (7, 27). This idea was
supported by the pair-wise identities determined from the
multiple sequence alignment (Table 4 and Fig. 5). This
analysis showed that representatives of each homology
group shared between 30 and 54% identity, but clearly CfxA,
with a maximum of 21% identity, was only distantly related.
CfxA then appears to belong to a new homology group of
class A enzymes, and further studies with other Bacteroides
1-lactamases will prove useful in establishing the identity of
this group.
The multiple sequence alignment also was interesting with
respect to the analysis of ,B-lactamase structure and function.
Eleven regions were identified that had a high degree of
similarity between all the sequences examined (Fig. 5).
These for the most part encompassed conserved secondary
structures or amino acid residues involved in the active site
or maintenance of the active-site depression (17). Previous
studies have identified 25 invariant amino acid residues in
class A sequences (7), and the multiple alignment generated
in the present report accurately aligned these residues for the
previously described enzymes. Inspection of the alignment
revealed that 13 of 25 invariant amino acid residues were
substituted in CfxA. A recent crystal structure analysis of
the S. aureus PC1 enzyme reported on 22 of these invariant
residues, and it appears that 6 of the CfxA substitutions are
in replaceable positions (17). For example, the Cys for
Leu-81 change is a conservative change consistent with its
location in a-helix 2, and the Met for Leu-169 change is also
very conservative. The other substitutions in replaceable
sites include Pro for Gly-156, Arg for Asp-157, Tyr for
Thr-180, and Ile for Leu-207, none of which are directly
involved in active-site structures.
The highly conserved active-site region near Ser-70 was
maintained in CfxA except for the notable substitution of
Tyr for Phe-66. Although CfxA is clearly not a class D
enzyme, it is interesting that four of five class D ,B-lactamase
sequences also have a Tyr-66 residue (7). The SDN loop also
is involved in catalysis, and these sequences were highly
conserved in all class A P-lactamases including CfxA. In
contrast, many other invariant positions involved in the
maintenance of the active site (of PC1) were altered in CfxA,
including Arg-164, which was replaced by a Tyr. It may be
significant that TEM-5, -7, -8, -9, -10, -12, and -26 have Ser
for Arg-164 substitutions leading to broader substrate spec-
ificity (6, 22).
Analysis of CfxA by SDS-PAGE indicated that the en-
zyme was between 35,000 and 38,000 Da (Fig. 3), and this
estimate was close to the size (35,375 Da) deduced from the
amino acid sequence. However, the molecular weight ob-
tained from the deduced amino acid sequence did not take
into account potential processing of a signal peptide. It is
possible that either the enzyme is not processed or it is
covalently modified, causing it to run aberrantly during
SDS-PAGE. An example of the latter is the B. cereus BCIII
3-lactamase, which is a covalently modified lipoprotein with
about half of the total activity membrane bound (20). The
close association of CfxA with the membrane fraction may
favor the possibility that CfxA is a covalently modified
lipoprotein.
3-Lactamases of gram-negative organisms are not gener-
ally membrane associated, but one that has been described is
from Capnocytophaga species (14). This was a clavulanic
acid-inhibitable cephalosporinase with many features similar
to CfxA including its apparent molecular weight of 38,000.
The cytophagas are gliding bacteria that appear to be related
to the Bacteroides/Flavobacteria group based on 16S rRNA
similarities (40). This phylogenetic group is apparently an-
cient, having branched very early from the main eubacterial
line of descent, and it will be interesting to see whether the
relationship between their ,B-lactamases supports this phylo-
genetic scheme.
In many Fxr Bacteroides species, there may be more than
one mechanism of resistance operating simultaneously. For
example, the situation with B. unifortnis WAL7088 clearly
indicates two mechanisms, an Fxr hydrolyzing ,B-lactamase
(which could be CfxA, Fig. 6), and altered penicillin binding
proteins (41). Our cloning results together with the insertion
mutant IB246fQpSUC2 clearly showed that acquisition of
cfxA is sufficient for expression of the Fxr phenotype. In
fact, ,B-lactamase of the CfxA type can lead to high-level
resistance (128 ,ug/ml) in the absence of other mechanisms,
and this could be the most important resistance mechanism.
This is supported by the analysis of 101 Fxr Bacteroides
strains with drug-inhibitor combinations (1). More than 90%
of these strains remained sensitive to clavulanate combina-
tions, indicating that 1-lactamase was primarily responsible
for resistance. While CfxA seems to be widely disseminated
based on our limited sample size, other slow cefoxitin-
hydrolyzing ,B-lactamases are present in the Bacteroides
species as suggested by the variety of pI values observed for
these enzymes from different sources (10, 13). As these are
studied in more detail, it should be possible to determine
their relationship to CfxA so that we can develop a better
understanding of antibiotic resistance dissemination in the
Bacteroides species.
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